Document Detail


Effect of cordycepin (3'-deoxyadenosine) on hematogenic lung metastatic model mice.
MedLine Citation:
PMID:  15796166     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
We investigated the anti-metastatic effect of cordycepin (3'-deoxyadenosine) on a hematogenic metastatic mouse model which was intravenously injected with B16-BL6 melanoma cells. A 3-hour exposure to various concentrations of cordycepin (0.3, 1 and 3 microg/ml) dose-dependently reduced the number of nodules formed in lung at 15 days after the tumor injection. To elucidate the mechanism of this anti-metastatic effect, we examined the effect of cordycepin on the invasiveness of B16-BL6 cells using a chemo-invasion chamber in vitro. The B16-BL6 cells pretreated with cordycepin (3 microg/ml) for 3 hours showed a significant decrease in invasiveness. Under the same conditions, however, cordycepin did not influence the growth curve of B16-BL6 cells at concentrations up to 3 microg/ml. These results suggest that cordycepin exerts an anti-metastatic action, in part, by inhibiting the invasiveness of mouse melanoma cells.
Authors:
Kazuki Nakamura; Keiko Konoha; Noriko Yoshikawa; Yu Yamaguchi; Satomi Kagota; Kazumasa Shinozuka; Masaru Kunitomo
Related Documents :
4001586 - Accuracy of clinical estimates of tumor dimensions. a clinical-pathologic correlation s...
11142696 - Dextran sulfate inhibits injured abdominal wall-specific tumor implantation in mice.
11395556 - Expression of melanocytic differentiation markers in malignant melanomas of the oral an...
15986136 - Ski pathways inducing progression of human melanoma.
16565356 - Anecortave acetate as single and adjuvant therapy in the treatment of retinal tumors of...
21888506 - Inhibitory effect of vitamin c in combination with vitamin k3 on tumor growth and metas...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  In vivo (Athens, Greece)     Volume:  19     ISSN:  0258-851X     ISO Abbreviation:  In Vivo     Publication Date:    2005 Jan-Feb
Date Detail:
Created Date:  2005-03-30     Completed Date:  2005-08-01     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8806809     Medline TA:  In Vivo     Country:  Greece    
Other Details:
Languages:  eng     Pagination:  137-41     Citation Subset:  IM    
Affiliation:
Department of Pharmacology, Faculty of Pharmaceutical Sciences, Mukogawa Women's University, Nishinomiya, Hyogo 663-8179, Japan. lfp51193@mwu.mukogawa-u.ac.jp
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Antineoplastic Agents / pharmacology*
Deoxyadenosines / pharmacology*
Disease Models, Animal*
Dose-Response Relationship, Drug
Female
Injections, Intravenous
Lung Neoplasms / prevention & control*,  secondary*
Melanoma, Experimental / pathology
Mice
Mice, Inbred C57BL
Neoplasm Invasiveness / prevention & control
Neoplasm Metastasis / prevention & control*
Neoplasm Transplantation
Specific Pathogen-Free Organisms
Time Factors
Tumor Cells, Cultured
Chemical
Reg. No./Substance:
0/Antineoplastic Agents; 0/Deoxyadenosines; 73-03-0/cordycepin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Antimetastatic activity of a synthetic serine protease inhibitor, FOY-305 (Foypan).
Next Document:  Effects of ellagic acid by oral administration on distribution and metabolism of 2-aminofluorene in ...